Please wait a minute...
Journal of ZheJiang University(Medical Science)  2015, Vol. 44 Issue (3): 237-246    DOI: 10.3785/j.issn.1008-9292.2015.05.01
Factors related to clinical pregnancy outcomes of in vitro fertilization-embryo transfer in women with secondary infertility
LIU Yi-feng, YE Xiao-qun, ZHU Lin-ling, HUANG Yun, WU Yi-qing, XU Peng, KONG Yu-jia, LIU Feng, SUN Sai-jun, ZHANG Dan
Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
Download: HTML (   PDF(894KB)
Export: BibTeX | EndNote (RIS)      


Objective: To investigate the factors related to clinical pregnancy outcomes of in vitro fertilization-embryo transfer(IVF-ET)in women with secondary infertility. Methods: The clinical, laboratory and follow-up data of 1129 cycles in 1099 patients with secondary infertility undergoing IVF-ET in Women's Hospital, Zhejiang University School of Medicine between July 2012 to July 2014 were retrospectively reviewed. The factors related to pregnancy outcomes were analyzed by univariate and logistic regression methods. The clinical pregnancy rates in women with different age and different number of embryos transferred were compared. The clinical outcomes of stimulation with gonadotropin releasing hormone(GnRH)agonist long protocol,GnRH agonist short protocol and GnH antagonist protocol were evaluated in secondary infertile patients aged≥40 years. Results: Among 1129 cycles, 376 cases(33.30%) had clinical pregnancy and 753 cases(66.70%)had no clinical pregnancy. There were significant differences in age, body mass index, basal follicle-stimulating hormone level, antral follicle number,paternal age and number of embryos transferred between pregnancy and no pregnancy groups(P<0.05); while only maternal age(OR=0.900,95%CI:0.873~0.928,P<0.001)and the number of embryos transferred(OR=2.248,95%CI:1.906~2.652,P<0.001)were the independent factors affecting the clinical pregnancy outcome of IVF-ET. There was no significant difference in clinical pregnancy rate between women aged 30~40 years with two embryos transferred and those aged<30 years with two or three embryos transferred(P>0.05). There were no significances in clinical pregnancy rate among women aged≥40 years using GnRH agonist long protocol,GnRH agonist short protocol and GnRH antagonist protocol for stimulation(P>0.05). Conclusion: Maternal age and number of embryos transferred have independent effect on IVF-ET clinical pregnancy outcome of secondary infertile women. We suggest that no more than two embryos should be transferred for women in their thirties to minimize the risk of multiple pregnancy while still having an acceptable pregnancy rate. The pregnancy rate of patients over 40 years decreases significantly, and there is no difference in pregnancy rate by using GnRH agonist long protocol,GnRH agonist short protocol or GnRH antagonist protocol.

Key wordsInfertility, female/therapy      Embryo transfer      Pregnancy rate      Fertilization in vitro      Fallopian tube diseases/complications      Logistic models      Retrospective studies     
Received: 03 December 2014      Published: 25 May 2015
CLC:  R743  
Cite this article:

LIU Yi-feng, YE Xiao-qun, ZHU Lin-ling, HUANG Yun, WU Yi-qing, XU Peng, KONG Yu-jia, LIU Feng, SUN Sai-jun, ZHANG Dan. Factors related to clinical pregnancy outcomes of in vitro fertilization-embryo transfer in women with secondary infertility. Journal of ZheJiang University(Medical Science), 2015, 44(3): 237-246.

URL:     OR


目的:比较再生育继发不孕妇女行体外受精—胚胎移植(IVF-ET)后不同临床妊娠结局的影响因素,评估各影响因素对临床妊娠结局的相对重要性,为妇女再生育指导提供科学依据。方法:回顾性分析2012年7月至2014年7月浙江大学医学院附属妇产科医院因再生育继发不孕行IVF-ET的1 099例妇女1 129个IVF-ET治疗周期的临床、实验室及随访资料。按是否临床妊娠分为两组,通过单因素分析和二元logistic回归分析研究再生育继发不孕妇女行IVF-ET治疗临床妊娠结局的影响因素;比较各年龄阶段不同胚胎移植数的临床妊娠结局;并分析比较促性腺激素释放激素(GnRH)激动剂长方案、GnRH激动剂短方案、GnRH拮抗剂方案等3种常用控制性超促排卵(COH)方案治疗≥40岁高龄再生育继发不孕妇女的助孕效果。结果:1 129个治疗周期中临床妊娠376例次(33.30%),未临床妊娠753例次(66.70%),这两组女方年龄、女方体质量指数、基础卵泡刺激素、窦卵泡数、移植胚胎数和男方年龄差异有统计学意义(均P<0.05)。二元logistic回归分析发现年龄(OR=0.900,95%CI:0.873~0.928,P<0.001)、移植胚胎数(OR=2.248,95%CI:1.906~2.652,P<0.001)是再生育继发不孕妇女行IVF-ET治疗临床妊娠是否成功的独立影响因素。30~40岁移植双胚胎与<30岁移植多胚胎妇女的临床妊娠率差异无统计学意义(P>0.05)。年龄≥40岁再生育继发不孕妇女应用GnRH激动剂长方案、GnRH激动剂短方案和GnRH拮抗剂方案三组妇女临床妊娠率差异无统计学意义(P>0.05)。结论:年龄和胚胎移植数是预测再生育继发不孕妇女行IVF-ET治疗临床妊娠结局的独立影响因素。30~40岁妇女建议移植胚胎数不超过2个。年龄≥40岁再生育继发不孕妇女的临床妊娠率显著降低,应用GnRH激动剂长方案、GnRH激动剂短方案、GnRH拮抗剂方案对其临床妊娠率无明显影响。

关键词: 不育,女(雌)性/治疗,  胚胎移植,  妊娠率,  受精,体外,  输卵管疾病/并发症,  Logistic模型,  回顾性研究 

[1] SURREY E S, SCHOOLCRAFT W B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques[J]. Fertil Steril, 2000,73(4):667-676.
[2] THUM M Y, ABDALLA H I, TAYLOR D. Relationship between women's age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment[J]. Fertil Steril, 2008,90(2):315-321.
[3] GOMES L M, CANHA ADOS S, DZIK A, et al. The age as a predictive factor in in vitro fertilization cycles [J]. Rev Bras Ginecol Obstet, 2009, 31(5):230-234.
[4] YAN J, WU K, TANG R, et al. Effect of maternal age on the outcomes of in vitro fertilization and embryo transfer (IVF-ET)[J]. Sci China Life Sci, 2012, 55(8):694-698.
[5] GRIFFITHS A, DYER S M, LORD S J, et al. A cost-effectiveness analysis of in vitro fertilization by maternal age and number of treatment attempts[J]. Hum Reprod, 2010, 25(4):924-931.
[6] VINCENT-ROHFRITSCH A, LE RAY C, ANSELEM O, et al. Pregnancy in women aged 43 years or older: maternal and perinatal risks[J]. Gynecol Obstet Biol Reprod, 2012, 41(5):468-475.
[7] LIU K, CASE A. Advanced reproductive age and fertility [J]. J Obstet Gynaecol Can, 2011, 33(11):1165-1175.
[8] WATT A H, LEGEDZA A T, GINSBURG E S, et al. The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization[J]. J Assist Reprod Genet, 2000, 17(5):264-268.
[9] FRAGOULI E, WELLS D, DELHANTY D. Chromosome abnormalities in the human oocyte[J]. Cytogenet Genome Res, 2011,133(2-4):107-118.
[10] SANDALINAS M, MARQUEZ C, MUNNE S. Spectral karyotyping of fresh, non-inseminated oocytes [J]. Mol Hum Reprod, 2002, 8(6): 580-585.
[11] KULIEV A, CIESLAK J, ILKEVITCH Y, et al. Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies[J]. Reprod Biomed Online, 2003, 6(1): 54-59.
[12] PELLESTOR F, ANDREO B, ARNAL F, et al. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes[J]. Hum Genet, 2003, 112(2):195-203.
[13] HASSOLD T, HALL H, HUNT P. The origin of human aneuploidy: where we have been, where we are going [J]. Hum Mol Genet, 2007,16(Spec No. 2):R203-R208.
[14] FRAGOULI E, ESCALONA A, GUTIERREZ-MATEO C, et al. Comparative genomic hybridization of oocytes and first polar bodies from young donors[J]. Reprod Biomed Online, 2009,19(2): 228-237.
[15] FRAGOULI E, KATZ-JAFFE M, ALFARAWATI S, et al. Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure [J]. Fertil Steril, 2010,94(3): 875-887.
[16] ZENZES M T, CASPER R F. Cytogenetics of human oocytes, zygotes and embryos after in vitro fertilisation[J]. Hum Genet, 1992, 88(4): 367-375.
[17] ANGELL R R. Predivision in human oocytes at meiosis I: a mechanism for trisomy formation in man [J]. Hum Genet, 1991, 86(4): 383-387.
[18] GRANDE M, BORRELL A, GARCIA-POSADA R, et al. The effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage[J]. Hum Reprod, 2012, 27(10):3109-3117.
[19] CHEN X, PROSSER R, SIMONETTI S, et al. Rearranged mitochondrial genomes are present in human oocytes[J]. Am J Hum Genet, 1995,57(2):239-247.
[20] KEEFE D L, NIVEN-FAIRCHILD T, POWELL S, et al. Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women[J]. Fertil Steril,1995,64(3):577-583.
[21] BARTMANN A K, ROMAO G S, RAMOS EDA S, et al. Why do older women have poor implantation rates? A possible role of the mitochondria[J]. J Assist Reprod Genet, 2004, 21(3):79-83.
[22] WILDING M, DI MATTEO L, DALE B. The maternal age effect: a hypothesis based on oxidative phosphorylation[J]. Zygote, 2005, 13(4):317-323.
[23] SEIFER D B, DEJESUS V, Hubbard K. Mitochondrial deletions in luteinized granulosa cells as a function of age in women undergoing in vitro fertilization[J]. Fertil Steril, 2002, 78(5):1046-1048.
[24] COHEN J, SCOTT R, ALIKANI M, et al. Ooplasmic transfer in mature human oocytes [J]. Mol Hum Reprod, 1998,4(3):269-280.
[25] TAKEUCHI T, NERI Q V, KATAGIRI Y, et al. Effect of treating induced mitochondrial damage on embryonic development and epigenesis[J]. Biol Reprod, 2005,72(3):584-592.
[26] BENTOV Y, ESFANDIARI N, BURSTEIN E, et al. The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients [J]. Fertil Steril, 2010,93(1):272-275.
[27] VAN ROOIJ I A, BANCSI L F, BROEKMANS F J, et al. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization[J]. Fertil Steril, 2003, 79(3):482-488.
[28] CHUANG C C, CHEN C D, CHAO K H, et al. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization [J]. Fertil Steril, 2003,79(1):63-68.
[29] CHECK J H, KATSOFF B, BRASILE D, et al. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels[J]. Clin Exp Obstet Gynecol, 2008, 35(1):13-15.
[30] MUTLU M F, ERDEM M, ERDEM A, et al. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles[J]. J Assist Reprod Genet, 2013, 30(5):657-665.
[31] KISSIN D M, KULKAMI A D, KUSHNIR V A, et al. Number of embryos transferred after in vitro fertilization and good perinatal outcome [J]. Obstet Gynecol,2014, 123(2):239-247.
[32] Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion[J]. Fertil Steril, 2013,99(1):44-46.
[33] KAUR P, SWARANKAR M L, MAHESHWARI M, et al. A comparative study between cleavage stage embryo transfer at day 3 and blastocyst stage transfer at day 5 in in vitro fertilization/intra-cytoplasmic sperm injection on clinical pregnancy rates[J].J Hum Reprod Sci, 2014, 7(3):194-197.
[34] FERNANDEZ-SHAW S, CERCAS R, BRANA C, et al. Ongoing and cumulative pregnancy rate after cleavage-stage versus blastocyst-stage embryo transfer using vitrification for cryopreservation: impact of age on the results[J]. J Assist Reprod Genet, 2015,32(2):177-184.
[35] ORVIETO R, HOMBURG R, MELTCER S, et al. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori[J]. Fertil Steril, 2009, 91(4 Suppl):1378-1380.
[36] 章晓梅.高龄不育妇女在体外受精一胚胎移植中的降调节[J].生殖医学杂志,2007,16(5):308-310. ZHANG Xiao-mei. Down regulation in older women undergoing IVF-ET [J]. Journal of Reproductive Medicine, 2007,16(5):308-310.(in Chinese)
[37] 倪 郝,陈雷宁,陈思梅,等. GnRH-a长方案和GnRH-ant方案在高龄患者IVF-ET中应用效果的比较[J]. 中国妇产科临床杂志, 2011,12(6): 406-409. NI Hao, CHEN Lei-ning, CHEN Si-mei, et al. Comparison of GnRH-agonist long protocol with GnRH-antagonist protocol in women with advanced reproductive-age undergoing IVF-ET[J]. Chinese Journal of Clinical Obstetetrics Gynecology, 2011,12(6): 406-409. (in Chinese)
[38] LUDWIG M, KATALINIC A, DIEDRICH K. Use of bGnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis[J]. Arch Gynecol Obstet, 2001,265(4):175-182.
[39] FRANCO J G, BARUFFI R L, MAURI A L, et al. GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis[J]. Reprod Biomed Online, 2006, 13(5):618-627.
[40] CHECK J H, CHOE J K, COHEN R, et al. A study to determine the efficacy of controlled ovarian hyperstimulation regimen using a gonadotropin releasing hormone agonist versus antagonist in women of advanced reproductive age with varying degrees of oocyte reserve on outcome following in vitro fertilization-embryo transfer[J]. Clin Exp Obstet Gynecol, 2013, 40(2):191-192.

[1] LOU Yelin,ZHOU Yimin,LU Hong,LYU Weiguo. Establishment of a prognostic model for preterm delivery in women after cervical conization[J]. Journal of ZheJiang University(Medical Science), 2018, 47(4): 351-356.
[2] LI Xiaoyong,SHEN Peng,LIN Hongbo,YU Zhebin,CHEN Kun,WANG Jianbing. A community-based survey on risk factors of type 2 diabetic kidney disease in Ningbo, China[J]. Journal of ZheJiang University(Medical Science), 2018, 47(2): 163-168.
[3] PEI Lei, XU Jingjing, ZHANG Minming. Correlation between high signal intensity in cerebrum nucleus on unenhanced T1-weighted MR images and number of previous gadolinium-based contrast agent administration[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 487-491.
[4] LI Aijing, PAN Yuning, CHEN Bin, XIA Jianbi, GAN Fang, JIN Yinhua, ZHENG Jianjun. Association of parameters in dynamic contrast-enhanced MRI using reference region model with prognostic factors and molecular subtypes of breast cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 505-510.
[5] LIU Chunmei, HUANG Pintong, WANG Yao, ZHANG Xu, YOU Xiangdong. Value of ultrasonography in diagnosis of xanthogranulomatous cholecystitis[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 552-556.
[6] HU Xiaorui, MO Fengyi, MA Qing, CUI Long, LYU Pingping, YE Yinghui. Correlation of fetuin-B concentrations in serum and follicular fluid with outcomes of in vitro fertilization[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 285-289.
[7] LI Enshu, YE Xiaoqun, FANG Li, YE Yinghui. Effect of oxygen concentration on outcome of in-vitro fertilization-embryo transfer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 290-294.
[8] SHI Biwei, CUI Long, YE Xiaoqun, YE Yinghui. Effects of embryo cryopreservation and thawing on clinical outcomes of transplantable embryos after cleavage-stage preimplantation genetic diagnosis or screening[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 295-299.
[9] FU Yanling, ZHU Yimin. Potential clinical application of Kisspeptin in reproductive endocrinology[J]. Journal of ZheJiang University(Medical Science), 2017, 46(3): 328-333.
[10] WU Han,WANG Zhongjin,MING Wenjie,WANG Shuang,DING Meiping. Monitoring time of interictal epileptiform discharges by long-term video EEG in patients with epilepsy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 30-35.
[11] XIA Guangfa, ZHU Juanying, YUAN Jun, CAO Bo, TANG Jie, CHEN Yiding. Efficacy of adjuvant endocrine therapy in breast cancer patients with a positive-to-negative switch of hormone receptor status after neoadjuvant chemotherapy[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 614-619.
[12] JIANG Qianqian, ZHULEPIYA Simayi, CHEN Yulan, ZHOU Xiaohuan, ZHANG Xiangyang, XU Xinjuan, YE Hong. Influencing factors of renal function in hypertensive patients with obstructive sleep apnea-hypopnea syndrome[J]. Journal of ZheJiang University(Medical Science), 2016, 45(3): 261-267.
[13] CHEN Xiaohong, XU Yiping, LU Meiping. Clinical characteristics and etiology of children with hypereosinophilia[J]. Journal of ZheJiang University(Medical Science), 2016, 45(3): 292-296.
[14] CHEN Siteng, YU Lixin, DENG Wenfeng, MIAO Yun, LIU Rumin, YE Guirong. Characteristics of urinary tract infection in kidney transplant recipients and non-recipient patients[J]. Journal of ZheJiang University(Medical Science), 2016, 45(2): 201-207.
[15] BIAN Wei, GUAN Jichao, XIE Xishao, TONG Jin, ZHANG Xiaohui, SHOU Zhangfei. Effects of interim hemodialysis on survival and clinical outcomes in patients with maintenance peritoneal dialysis[J]. Journal of ZheJiang University(Medical Science), 2016, 45(2): 195-200.